Wolverine Trading, LLC Brainstorm Cell Therapeutics Inc. Put Options Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 23, 2023	BUY	$2.0 - $3.2 $38,600 - $61,760	19,300 Added 189.22%	29,500 $60,000
Q1 2023 May 15, 2023	BUY	$1.43 - $3.3 $14,586 - $33,660	10,200 New	10,200 $26,000
Q2 2021 Aug 06, 2021	SELL	$3.01 - $4.01 $44,548 - $59,348	-14,800 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.46 - $7.88 $59,858 - $136,324	-17,300 Reduced 53.89%	14,800 $55,000
Q4 2020 Feb 12, 2021	BUY	$3.99 - $17.73 $128,079 - $569,133	32,100 New	32,100 $149,000
Q1 2020 May 11, 2020	SELL	$4.01 - $8.88 $85,012 - $188,256	-21,200 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$3.62 - $4.29 $63,350 - $75,075	-17,500 Reduced 45.22%	21,200 $91,000
Q3 2019 Nov 14, 2019	SELL	$3.54 - $4.48 $60,888 - $77,056	-17,200 Reduced 30.77%	38,700 $150,000
Q2 2019 Aug 20, 2019	BUY	$3.59 - $4.3 $98,725 - $118,250	27,500 Added 96.83%	55,900 $221,000
Q1 2019 May 15, 2019	BUY	$3.37 - $4.34 $95,708 - $123,256	28,400 New	28,400 $123,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.